2. Signaling Pathways
  3. Others
  4. Drug Intermediate

Drug Intermediate

Drug Iintermediate

Drug intermediates are used as raw materials for the production of bulk drugs, or they can refer to a material produced during synthesis of an API that must undergo further molecular change or processing before it becomes an API. Drug intermediates are hygienically formulated using high grade raw materials and they are used in the pharmaceutical and cosmetic industry[1][2].

Drug Intermediate Related Products (4327):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-W040233
    L-Lactic acid sodium
    		98.54%
    L-lactate Sodium (Sodium (S)-2-hydroxypropanoate) is a buildiing block which can be used as a precursor for the production of the bioplastic polymer poly-lactic acid. L-Lactic acid Sodium has antiproliferative activity.
    L-Lactic acid sodium
  • HY-Y1636
    Fmoc-Arg(Pbf)-OH
    		99.97%
    Fmoc-Arg(Pbf)-OH is an arginine derivative containing amine protecting group Fmoc. Fmoc-Arg(Pbf)-OH is a building block for the introduction of Arg into SPPS (Solid-Phase Peptide Synthesis).
    Fmoc-Arg(Pbf)-OH
  • HY-30536
    tert-Butyl 3,9-diazaspiro[5.5]undecane-3-carboxylate
    		99.98%
    tert-Butyl 3,9-diazaspiro[5.5]undecane-3-carboxylate is a drug intermediate for synthesis of various active compounds.
    tert-Butyl 3,9-diazaspiro[5.5]undecane-3-carboxylate
  • HY-W008125
    Acetobromo-α-D-glucuronic acid methyl ester, 98%
    		99.93%
    Acetobromo-α-D-glucuronic acid methyl ester, 98% is a glucuronosyl donor. Acetobromo-α-D-glucuronic acid methyl ester, 98% is applicable to the synthesis of other compounds.
    Acetobromo-α-D-glucuronic acid methyl ester, 98%
  • HY-W007465
    4-Aminobenzyl alcohol
    		99.86%
    4-Aminobenzyl alcohol is a self-eliminating linker. 4-Aminobenzyl alcohol can be used to synthesize the fluorescent probe MB-Van1 targeting Vanin-1.
    4-Aminobenzyl alcohol
  • HY-W017776
    BG-NH2
    BG-NH2 is a pharmaceutical intermediate. BG-NH2 is suitable for synthesizing fluorescent SNAP tag substrates to label RNA.
    BG-NH2
  • HY-W453851
    Boc-3,3-DicPr-Ala-OH
    Boc-3,3-DicPr-Ala-OH is a chiral amino acid intermediate used in the synthesis of IL-17 modulators. Boc-3,3-DicPr-Ala-OH can be used to synthesize IL-17 modulators for research on diseases such as skin disorders.
    Boc-3,3-DicPr-Ala-OH
  • HY-69024
    1-Methyl-1H-indazol-5-amine
    		99.10%
    1-Methyl-1H-indazol-5-amine is a drug intermediate that can be used for the synthesis of TRPM5 agonists.
    1-Methyl-1H-indazol-5-amine
  • HY-A0104
    HPMC (Viscosity:11250-21000mPa.s)
    HPMC (Viscosity:11250-21000mPa.s) is a hydrophilic, non-ionic cellulose ether used to form swellable-soluble matrices.
    HPMC (Viscosity:11250-21000mPa.s)
  • HY-N7033
    UDP-glucuronic acid trisodium
    		99.87%
    UDP-​glucuronic acid trisodium (Uridine-5'-diphosphoglucuronic acid trisodium salt) is a critical precursor for essential glycoconjugates across biological kingdoms, ranging from mammalian glycosaminoglycans and plant cell wall polysaccharides to bacterial capsule glycoglycerolipids.
    UDP-glucuronic acid trisodium
  • HY-W048541A
    (R)-5,7-Difluorochroman-4-ol
    		99.98%
    (R)-5,7-Difluorochroman-4-ol is a drug intermediate for synthesis of various active compounds.
    (R)-5,7-Difluorochroman-4-ol
  • HY-W008510
    2-Chloro-5-(trifluoromethyl)pyrimidine
    		99.96%
    2-Chloro-5-(trifluoromethyl)pyrimidine is a chemical intermediate. It can be used in the synthesis of inducers of intracellular STAT1 phosphorylation.
    2-Chloro-5-(trifluoromethyl)pyrimidine
  • HY-132832
    Sirpiglenastat
    		99.13%
    Sirpiglenastat (DRP-104) is a broad acting glutamine antagonist. Sirpiglenastat has anticancer effects by directly targeting tumor metabolism and simultaneously inducing a potent antitumor immune response.
    Sirpiglenastat
  • HY-20556
    DBU
    		99.87%
    DBU (1,8-diazabicyclo[5.4.0]undec-7-ene) is a bicyclic sterically hindered amidine with strong basicity, which possesses multiple properties such as nucleophilicity and coordination ability. DBU is prone to hydrolysis and can undergo addition, substitution, cyclization and other reactions with various substrates to form derivatives containing its scaffold. DBU can also be used as a catalyst.
    DBU
  • HY-W021377
    Exatecan Intermediate 2
    		99.99%
    Exatecan Intermediate 2 (Compound B) is an intermediate of Exatecan (DX-8951, HY-13631). Exatecan is an anticancer agent belonging to the class of camptothecin analogs. Exatecan interferes with the proliferation and division of tumor cells by interacting with DNA, thereby inhibiting tumor growth. Exatecan is primarily used for research of a variety of cancers including ovarian, lung and breast cancers.
    Exatecan Intermediate 2
  • HY-59156
    Triazabicyclodecene
    		99.52%
    Triazabicyclodecene is a type of bicyclic glycone compound that can be used as a drug intermediate to form amides or esters.
    Triazabicyclodecene
  • HY-W441592
    (4-Bromo-2-(methylamino)phenyl)diethylphosphine oxide
    		99.83%
    (4-Bromo-2-(methylamino)phenyl)diethylphosphine oxide is a drug intermediate for synthesis of various active compounds.
    (4-Bromo-2-(methylamino)phenyl)diethylphosphine oxide
  • HY-20138
    2-Fluoro-5-formylbenzonitrile
    		99.67%
    2-Fluoro-5-formylbenzonitrile is a drug intermediate for synthesis of various active compounds.
    2-Fluoro-5-formylbenzonitrile
  • HY-W005983
    6-Chloropyrimidine-4-carboxylic acid
    		98.72%
    6-Chloropyrimidine-4-carboxylic acid is a drug intermediate for synthesis of various active compounds.
    6-Chloropyrimidine-4-carboxylic acid
  • HY-43384
    Chloromethyl methyl carbonate
    		99.28%
    Chloromethyl methyl carbonate (Tenofovir Impurity 66) is a drug intermediate for synthesis of various active compounds.
    Chloromethyl methyl carbonate